With its latest $50 billion U.S. manufacturing investment and record U.S. growth, is British AstraZeneca looking at itself as ...

AstraZeneca's drive to rebuild its portfolio of new medicines received a boost with positive results for an experimental biotech drug for severe asthma that the company previously flagged as a ...

The Allergy & Asthma Network praised three major pharmaceutical companies, AstraZeneca, Boehringer Ingelheim and GSK, that announced they will enact a $35 price cap on their inhaler products ...

Eur Respir J. 2019;54 (3):1900900. Price DB, et al. Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study. J Asthma Allergy. 2018;11:193-204. GOLD.

GSK plc’s GSK Specialty Medicines segment includes medicines that prevent and treat diseases like HIV, cancer, asthma and immune-inflammation diseases like lupus. Specialty Medicines now represents ...

Papi A, et al. Relationship of inhaled corticosteroid adherence to asthma exacerbations in patients with moderate-to-severe asthma. J Allergy Clin Immunol Pract. 2018; 6 (6): 1989-98.e3.

WILMINGTON, Del. -- (BUSINESS WIRE)-- Positive high-level results from the Phase III KALOS and LOGOS trials in patients with uncontrolled asthma showed that AstraZeneca’s fixed-dose triple ...

AstraZeneca’s Tezspire receives European approval to treat severe asthma Cambridge, UK Thursday, September 22, 2022, 09:00 Hrs [IST] AstraZeneca’s Tezspire (tezepelumab) has been approved in the ...

CHMP recommends marketing authorization for AstraZeneca’s Tezspire in EU to treat severe asthma Cambridge, UK Tuesday, July 26, 2022, 09:00 Hrs [IST] AstraZeneca’s Tezspire (tezepelumab) has been ...

AstraZeneca is conducting a non-interventional, prospective study titled ‘A Non-interventional, Prospective Study With Benralizumab to Investigate Clinical Outcome Based on Standard of Care ...

LABAs, which are also used to treat the more serious lung condition chronic obstructive pulmonary disease (COPD), are blockbuster products for the companies with Advair's sales reaching about $7.8 ...